Vaccinations is a discipline in medicine where everything moves fast. This presentation will help delegates keep up with changes in vaccinations and immunisations.

This session will address some of the key issues which impact the delivery of travel health services in a primary care setting. It will consider some of the most frequently asked questions for travel vaccines and look briefly at a selection of new products on the market, available for travellers.

There is little doubt of the value of vaccinations and immunisation. Global travel has provided pathogens the opportunity to relocate rapidly and extensively. The impact of this can be devastating on individuals, families, communities and the wider global community. Vaccine Hesitancy is growing driven by a number of factors. This presentation will review the importance of travel vaccination and focus on Vaccine Hesitancy, how it can be understood and strategies for addressing this.

Since 2020, the development and distribution of vaccines have undergone transformative changes. The COVID-19 pandemic accelerated the adoption of mRNA technology and this innovation has broadened the horizon for vaccines targeting other diseases, such as cancer and malaria. Global vaccine production and distribution systems improved but disparities in access and uptake of vaccines remain an issue. Growing vaccine hesitancy and misinformation have become key challenges post COVID-19. Uptake also varies across the UK due to decreasing trust, infrastructure, and socioeconomic conditions. This session will look at what has redefined the landscape of immunization, highlighting both achievements and ongoing challenges.

This session will consider the role of vaccination in pregnancy and the various vaccine programmes recommended for pregnant women. In the UK pregnant women are routinely recommended to receive vaccines against influenza, Pertussis, Respiratory Syncytial virus (RSV). The session will discuss these vaccine programmes and the rationale for protecting the pregnant women, the unborn infant and newborn baby for the first few months of life.

Vaccinations is a discipline in medicine where everything moves fast. This presentation will help delegates keep up with changes in vaccinations and immunisations.

There is little doubt of the value of vaccinations and immunisation. Global travel has provided pathogens the opportunity to relocate rapidly and extensively. The impact of this can be devastating on individuals, families, communities and the wider global community. Vaccine Hesitancy is growing driven by a number of factors. This presentation will review the importance of travel vaccination and focus on Vaccine Hesitancy, how it can be understood and strategies for addressing this.

Hidradenitis Suppurativa (HS) is a chronic inflammatory disease of the hair follicle that presents with deep seated lesions in areas rich in apocrine glands. HS is a debilitating condition that often affects emotional wellbeing, life quality, and can place a substantial burden on all those living with the condition, the NHS and broader society. Managing HS lesions is a daily challenge, requiring anti inflammatory and analgesic medications, as well as frequent dressing changes. This presentation will focus on the new international consensus document which aims to provide clinicians with confidence and a practical standardised care pathway for diagnosing, assessing and managing HS lesions

This session will address some of the key issues which impact the delivery of travel health services in a primary care setting. It will consider some of the most frequently asked questions for travel vaccines and look briefly at a selection of new products on the market, available for travellers.

Since 2020, the development and distribution of vaccines have undergone transformative changes. The COVID-19 pandemic accelerated the adoption of mRNA technology and this innovation has broadened the horizon for vaccines targeting other diseases, such as cancer and malaria. Global vaccine production and distribution systems improved but disparities in access and uptake of vaccines remain an issue. Growing vaccine hesitancy and misinformation have become key challenges post COVID-19. Uptake also varies across the UK due to decreasing trust, infrastructure, and socioeconomic conditions. This session will look at what has redefined the landscape of immunization, highlighting both achievements and ongoing challenges.

 This session will consider the role of vaccination in pregnancy and the various vaccine programmes recommended for pregnant women. In the UK pregnant women are routinely recommended to receive vaccines against influenza, Pertussis, Respiratory Syncytial virus (RSV). The session will discuss these vaccine programmes and the rationale for protecting the pregnant women, the unborn infant and newborn baby for the first few months of life.